QuidelOrtho (QDEL) Depreciation & Amortization (CF) (2021 - 2026)
QuidelOrtho recorded quarterly Depreciation & Amortization (CF) of $112.9 million in Q1 2026, little changed quarter-over-quarter from $112.5 million in Q4 2025, and up 5.42% year-over-year from $107.1 million in Q1 2025.
QuidelOrtho's Depreciation & Amortization (CF) history runs 6 years deep, the most recent figure standing at $112.9 million for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) rose 5.42% year-over-year to $112.9 million; the TTM figure through Mar 2026 stood at $447.8 million (changed 0.49% YoY), while the FY2025 annual figure was $442.0 million, down 2.51% from the prior year.
- Depreciation & Amortization (CF) came in at $112.9 million for Q1 2026 at QuidelOrtho, roughly flat from $112.5 million in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $246.3 million in Q1 2023 to a low of $15.3 million in Q2 2022.
- A 5-year average of $110.5 million and a median of $112.9 million in 2026 frame the typical range for Depreciation & Amortization (CF).
- Across the five-year window, Depreciation & Amortization (CF) surged 720.47% in 2022 and tumbled 53.15% in 2023, its largest moves.
- QuidelOrtho's Depreciation & Amortization (CF) stood at $104.2 million in 2022, then gained by 10.75% to $115.4 million in 2023, then fell by 5.29% to $109.3 million in 2024, then advanced by 2.93% to $112.5 million in 2025, then climbed by 0.36% to $112.9 million in 2026.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $112.9 million, $112.5 million, and $112.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 749.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 67.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 123.40 Mn |
| 10 | QuidelOrtho | 898.19 Mn | 757.79 Mn | - | 112.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | 112.90 Mn |
| Mar 29, 2026 | 112.90 Mn |
| Dec 28, 2025 | 112.50 Mn |
| Dec 28, 2025 | 112.50 Mn |
| Sep 28, 2025 | 112.10 Mn |
| Sep 28, 2025 | 112.10 Mn |
| Jun 29, 2025 | 110.30 Mn |
| Jun 29, 2025 | 110.30 Mn |
| Mar 30, 2025 | 107.10 Mn |
| Mar 30, 2025 | 107.10 Mn |
| Dec 29, 2024 | 109.30 Mn |
| Dec 29, 2024 | 109.30 Mn |
| Sep 29, 2024 | 113.10 Mn |
| Sep 29, 2024 | 113.10 Mn |
| Jun 30, 2024 | 116.10 Mn |
| Jun 30, 2024 | 116.10 Mn |
| Mar 31, 2024 | 114.90 Mn |
| Mar 31, 2024 | 114.90 Mn |
| Dec 31, 2023 | 115.40 Mn |
| Dec 31, 2023 | 115.40 Mn |
| Oct 1, 2023 | 113.10 Mn |
| Oct 1, 2023 | 113.10 Mn |
| Jul 2, 2023 | 114.50 Mn |
| Jul 2, 2023 | 114.50 Mn |
| Apr 2, 2023 | 114.20 Mn |
| Apr 2, 2023 | 114.20 Mn |
| Jan 1, 2023 | 246.30 Mn |
| Jan 1, 2023 | 246.30 Mn |
| Oct 2, 2022 | 104.20 Mn |
| Oct 2, 2022 | 104.20 Mn |
| Jul 3, 2022 | 47.50 Mn |
| Jul 3, 2022 | 47.50 Mn |
| Apr 3, 2022 | 15.30 Mn |
| Apr 3, 2022 | 15.30 Mn |
| Oct 3, 2021 | 12.70 Mn |
| Oct 3, 2021 | 12.70 Mn |
| Jul 4, 2021 | 12.30 Mn |
| Jul 4, 2021 | 12.30 Mn |